• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mitochondrial cyclophilin D promotes disease tolerance by licensing NK cell development and IL-22 production against influenza virus - Cell

Mary Wilson

Well-known member
JUNE 21, 2022

DOI:https://doi.org/10.1016/j.celrep.2022.110974

Jeffrey Downey, Haley E. Randolph, Erwan Pernet, ..., Irah L. King,
Luis B. Barreiro, Maziar Divangahi


Highlights

  • Mitochondrial CypD is required to protect against severe influenza infection

  • CypD expression promotes NK cell lymphopoiesis and maturation

  • NK cell-derived IL-22 enhances disease tolerance during influenza infection

  • Transfer of WT NK cells confers protection in CypD[SUP]−/−[/SUP] mice to influenza infection
SUMMARY

Severity of pulmonary viral infections, including influenza A virus (IAV), is linked to excessive immunopa- thology, which impairs lung function. Thus, the same immune responses that limit viral replication can concomitantly cause lung damage that must be countered by largely uncharacterized disease tolerance mechanisms. Here, we show that mitochondrial cyclophilin D (CypD) protects against IAV via disease tolerance. CypD/mice are significantly more susceptible to IAV infection despite comparable antiviral im- munity. This susceptibility results from damage to the lung epithelial barrier caused by a reduction in inter- leukin-22 (IL-22)-producing natural killer (NK) cells. Transcriptomic and functional data reveal that CypD/NK cells are immature and have altered cellular metabolism and impaired IL-22 production, correlating with dysregulated bone marrow lymphopoiesis. Administration of recombinant IL-22 or transfer of wild- type (WT) NK cells abrogates pulmonary damage and protects CypD/mice after IAV infection. Collectively, these results demonstrate a key role for CypD in NK cell-mediated disease tolerance.

https://www.cell.com/action/showPdf?pii=S2211-1247(22)00760-4
 
Back
Top Bottom